Literature DB >> 2721172

Frequency characteristics of the heart rate variability produced by Cheyne-Stokes respiration during 24-hr ambulatory electrocardiographic monitoring.

Y Ichimaru1, T Yanaga.   

Abstract

Spectral analysis of heart rates during 24-hr ambulatory electrocardiographic monitoring has been carried out to characterize the heart rate spectral components of Cheyne-Stokes respiration (CSR) by using fast Fourier transformation (FFT). Eight patients with congestive heart failure were selected for the study. FFT analyses have been performed for 614.4 sec. Out of the power spectrum, five parameters were extracted to characterize the CSR. The low peak frequencies in eight subjects were between 0.0179 Hz (56 sec) and 0.0081 Hz (123 sec). The algorithms used to detect CSR are the followings: (i) if the LFPA/ULFA ratios were above the absolute value of 1.0, and (ii) the LFPP/MLFP ratios were above the absolute values of 4.0, then the power spectrum is suggestive of CSR. We conclude that the automatic detection of CSR by heart rate spectral analysis during ambulatory ECG monitoring may afford a tool for the evaluation of the patients with congestive heart failure.

Entities:  

Mesh:

Year:  1989        PMID: 2721172     DOI: 10.1016/0010-4809(89)90003-7

Source DB:  PubMed          Journal:  Comput Biomed Res        ISSN: 0010-4809


  3 in total

1.  Circadian rhythm of autonomic activity in patients with obstructive sleep apnea syndrome.

Authors:  A Noda; F Yasuma; T Okada; M Yokota
Journal:  Clin Cardiol       Date:  1998-04       Impact factor: 2.882

2.  Heart rate and respiratory rhythm dynamics on ascent to high altitude.

Authors:  L A Lipsitz; F Hashimoto; L P Lubowsky; J Mietus; G B Moody; O Appenzeller; A L Goldberger
Journal:  Br Heart J       Date:  1995-10

3.  Use of high-frequency peak in spectral analysis of heart rate increment to improve screening of obstructive sleep apnoea.

Authors:  Laurent Poupard; Isabelle Court-Fortune; Vincent Pichot; Florian Chouchou; Jean-Claude Barthélémy; Frédéric Roche
Journal:  Sleep Breath       Date:  2010-11-21       Impact factor: 2.816

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.